The Tuberculosis Testing Market Report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2031.
The Tuberculosis Testing Market report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint.
The global tuberculosis testing market report has been segmented on the basis of test type, end-user, and region.
Tuberculosis Testing Market Overview:
“The Tuberculosis Testing Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031.”
Tuberculosis (TB) is one of the leading infectious diseases in the world. Tuberculosis is caused by infection of the mycobacteria complex typically Mycobacterium tuberculosis (MTB).
Other species such as M. africanum and M. Bovis are also responsible for TB infection. Tuberculosis is transmitted from person to person by respiratory droplets.
The bacteria usually attack the lungs but can infect any part of the body such as the kidney, intestine, pleura, spine, and brain.
The selection of the most suitable tests for detection of M. tuberculosis infection should be based on the context for testing, test availability, and overall cost-effectiveness of testing.
Early screening and targeted testing for tuberculosis (TB) is a key strategy for controlling and preventing infection. According to WHO, in 2015 an estimated 10.4 million people had tuberculosis, and 1.8 million people died.
A key driver of the global tuberculosis testing market is the increasing global prevalence of tuberculosis infection.
In addition, the growing geriatric population, growing focus on awareness programs by the government and NGOs across the globe, and availability of new improved tests for TB, are contributing to the global growth of this market.
However, the high cost of the testing procedures and the requirement of specialized equipment for testing may hinder the growth of the global tuberculosis testing market.
As the technology advances, new point-of-care tests for TB and drug-resistant TB tests will become available on the market, and, with affordable prices of tests as well as physicians, patients, governments and global health agencies are looking for new ways to quickly and accurately identify active tuberculosis.
The market in the Asia Pacific is expected to dominate the market of global tuberculosis testing market, due to increasing cases of tuberculosis.
Countries such as China and India have the highest number of TB cases globally which is a major public health threat despite being a curable disease.
According to WHO, in 2015, the largest number of new TB cases occurred in the Asia-Pacific region with 61% of new cases, followed by the Middle East & Africa, with 26% of new cases.
The market in Middle East & Africa is expected to be an emerging market in the global tuberculosis testing market, owing to the increasing prevalence of tuberculosis. According to WHO, in 2016 about 2.5 million are suffering from TB in the African region, accounting for a quarter of new TB cases worldwide.
Tuberculosis Testing Market Segmentation:
Segmentation by test type:
- Nucleic acid testing (NAT)
- Mantoux test (TST)
- Smear microscopy
- IGRA (interferon-gamma release assays)
- Culture-based tests
- Chest x-ray
- Xpert test
- Serological tests
- Others (including, drug susceptibility testing, adenosine deaminase (ADA), etc.)
Segmentation by end-user:
- Hospital laboratories
- Research laboratories
- Clinics laboratories
- Diagnostic center
- Others (including, home health agencies, etc.)
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- LIONEX Diagnostics & Therapeutics GmbH
- Thermo Fisher Scientific Inc.
- Hoffmann-La Roche Ltd.
- Hain Life science GmbH
- Creative Diagnostics
- Abbott Laboratories
- Becton, Dickinson and Company
- Epistem Holdings Plc.
- Alere Inc.
- Hologic Inc.
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!